Introduction:
Commercially
available stents are only sub-optimally biocompatible leading to
intrinsic thrombogenicity, restenosis due to smooth muscle cell (SMC)
hyperproliferation and reduced endothelialization1 . We aim to modify a 316 L
stainless steel (SS) surface with a plasma activated coating (PAC), to
covalently bind proteins such as tropoelastin (TE) in their active state and
improve biofunctionalization, which can then be adapted to a 316L SS stent
platform.
Methods:
i) Surface integrity: measured compressive stress, refractive index, contact
angle, attachment of TE and percentage [N],[O] atomic composition of N2/Ar
PAC compared to other PAC compositions (H2/Ar, O2/Ar). ii)
Endothelialization: attachment and proliferation of
endothelial cells on PAC+TE vs 316LSS assessed with crystal violet staining. iii)
Thrombogenicity assays: In vitro modified chandler loop model rotated with
heparinised whole blood (0.5U/mL and 0.1 U/mL for flat sheets and stents respectively) at 370C, clot
formation assessed at 3 time points of 30, 60 and 90 mins for both flat sheets
and stents.
Results:
i) Compressive stress (<0.25 GPa), refractive index (<1.75),
wettability/contact angle (<600) and higher TE attachment after
SDS washing for N2/Ar PAC compared to other coating compositions
(P<0.05) ii) Endothelial cell proliferation markedly increased in PAC+TE
compared to 316LSS (P<0.05). ) iii) After 30 mins there was clot formation
on 316LSS, these features weren’t observed with PAC/PAC+TE flat sheets at any
time point up to 60 mins2 . With stents, at 60 mins, the thrombus formation was
dramatically low in PAC stents compared to BMS.
Discussion:
Lower compressive stress, lower refractive index account for higher elasticity
and biointegration of material, contact angle of <600-800
indicates mild hydrophilicity for optimal cell/blood compatibility. Higher TE
attachment after SDS washing on N2/Ar PAC indicates covalent
attachment of TE which promotes endothelialization3 . Low thrombogenicity observed;
decreases intrinsic and late stent thrombogenicity post-implantation and is a characteristic specifically important for cardiovascular devices.
Conclusion:
Most favourable plasma coating is N2/Ar PAC and TE the best
candidate for covalent attachment to the PAC flat sheet surface or stent to promote
endothelialization and inhibit thrombogenicity. In vivo translational studies comparing the biocompatibility of BMS
with PAC stents will be done in a porcine coronary stent model following the in vitro optimization studies of PAC stents.